Philip Roehrs MD
Associate Professor, Pediatrics Levine Children’s Hospital Charlotte,NC
Join to View Full Profile
1001 Blythe BlvdMedical Center Plaza Ste 601Charlotte, NC 28203
Phone+1 704-381-9900
Fax+1 704-355-5073
Dr. Roehrs is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Cincinnati Children's Hospital Medical CenterFellowship, Pediatric Hematology/Oncology, 2005 - 2008
- Medical University of South CarolinaResidency, Pediatrics, 2002 - 2005
- University of South Carolina School of MedicineClass of 2002
Certifications & Licensure
- VA State Medical License 2021 - 2026
- NC State Medical License 2010 - 2022
- OH State Medical License 2005 - 2012
- SC State Medical License 2004 - 2005
- American Board of Pediatrics Pediatric Hematology-Oncology
Clinical Trials
- Administration of Autologous CAR-T CD19 Antigen With Inducible Safety Switch in Patients With Relapsed/Refractory ALL Start of enrollment: 2012 Mar 22
Publications & Presentations
PubMed
- 1 citationsTerminal Lucidity in a Pediatric Oncology Clinic.Philip Roehrs, Peter Fenwick, Bruce Greyson, Allan Kellehear, Karalee Kothe
The Journal of Nervous and Mental Disease. 2024-01-01 - 4 citationsBiallelic variants in ribonuclease inhibitor (RNH1), an inflammasome modulator, are associated with a distinctive subtype of acute, necrotizing encephalopathy.Vandana Shashi, Kelly Schoch, Rebecca Ganetzky, Peter G Kranz, Neal Sondheimer
Genetics in Medicine. 2023-09-01 - 3 citationsAlemtuzumab and CXCL9 levels predict likelihood of sustained engraftment after reduced-intensity conditioning HCT.Ashley V Geerlinks, Brooks Scull, Christa Krupski, Ryan Fleischmann, Michael A Pulsipher
Blood Advances. 2023-07-25
Journal Articles
- Reduced Intensity Conditioning for Hematopoietic Cell Transplant for HLH and Primary Immune Deficiencies: BMT CTN 1204Shalini Shenoy, K Scott Baker, Elizabeth O Stenger, Mary Eapen, Carl Allen, Lauri Burroughs, Philip Roehrs, Catherine M Bollard, Rabi Hanna, Jeffrey R Andolina, James ..., Blood
Press Mentions
- Bone Marrow Transplant and Cellular TherapiesSeptember 9th, 2019
- Bringing Groundbreaking Immunotherapy to the Patients of North CarolinaJuly 22nd, 2015
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: